We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Agilent Technologies Introduces High-Capacity Human-14 Protein Removal System for Proteomic Biomarker Discovery
Product News

Agilent Technologies Introduces High-Capacity Human-14 Protein Removal System for Proteomic Biomarker Discovery

Agilent Technologies Introduces High-Capacity Human-14 Protein Removal System for Proteomic Biomarker Discovery
Product News

Agilent Technologies Introduces High-Capacity Human-14 Protein Removal System for Proteomic Biomarker Discovery


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Agilent Technologies Introduces High-Capacity Human-14 Protein Removal System for Proteomic Biomarker Discovery"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Agilent Technologies Inc. has introduced a version of its Multiple Affinity Removal System (MARS), the Human-14, which removes 95 percent to 99 percent of the 14 most abundant proteins from human blood serum and plasma in one easy step.

These high-abundance proteins account for 94 percent of the total protein mass, and removing them facilitates the discovery and identification of low-abundance proteins that may be biomarkers for a wide range of diseases.

Proteins associated with diseases are typically present in small amounts in human serum and may be difficult to isolate amid high-abundance proteins, such as albumin and immunoglobulin G. By reducing by half the number of proteins masking potential biomarkers, the new Agilent Human-14 products help researchers delve more deeply into the human proteome and advance the progress of proteomic research.

The MARS Hu-14 joins Agilent’s successful line of protein fractionation products. The family includes: the MARS Human-7, MARS Human-6HC, MARS Human-6, and MARS Mouse-3 columns and spin cartridges.

The Agilent MARS Hu-14 is available in both HPLC column and spin cartridge formats, facilitating protein removal through liquid chromatography or centrifugation techniques. The high-capacity products can be used for more than 200 runs, allowing immunodepletion of more than 8,000 microliters of serum or plasma using a single standard column format.

Advertisement